Risk Prediction of Bleeding in Liver Cirrhosis by Combi-elastography (NCT04640350) | Clinical Trial Compass
UnknownNot Applicable
Risk Prediction of Bleeding in Liver Cirrhosis by Combi-elastography
China300 participantsStarted 2020-12-31
Plain-language summary
Through the parameters of liver stiffness and spleen stiffness obtained by combi-elastography technique, summarize and analyze the warning index of esophagogastric variceal bleeding in patients with cirrhosis, so as to provide a new and valuable technique for clinical diagnosis.
Who can participate
Age range18 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* 18-80 years old, no gender limit;
* The clinical diagnosis is in line with patients with liver cirrhosis caused by chronic hepatitis B, and the gastroscopy is in line with the indications of portal hypertension;
* Gastroscopy needs to provide the degree of gastroesophageal varices;
* Sign the informed consent form.
Exclusion Criteria:
* Patients with cirrhosis and portal hypertension because of other causes or combined with other causes(such as viral hepatitis other than hepatitis B,Autoimmune liver disease, alcoholic liver disease, metabolism-related fatty liver disease, etc.)
* Patients with a history of spleen-related operations, such as splenectomy, splenic embolism;
* Patients undergoing portosystemic shunt or TIPS;
* Isolated esophageal venous tumor and its bleeding patients;
* History of upper gastrointestinal tumor or bleeding from gastric ulcer , etc;
* Those with serious diseases of other systems that cannot cooperate with elastography examination, such as heart failure, renal failure, mental illness, etc;
* Ascites before liver and spleen result unable to complete elasticity examination;
* Pregnant patients.